Establish a Diagnostic Model Based on Multiple Molecule Profiling and Certain Established Markers for Identification of Pancreatic Cancer
Status: Recruiting
Location: See location...
Intervention Type: Diagnostic test
Study Type: Observational
SUMMARY
Explore new markers based on portal venous blood sampling to establish novel diagnostic models for identification of malignant pancreatic mass.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 80
View:
• age 18-75 years,male or female
• diagnosis or suspection of solid pancreatic mass based on previous imaging examination (ultrasonography, CT or MRI)
• lesion diameter larger than 1 cm
• signed informed consent letter
Locations
Other Locations
China
Changhai Hospital
RECRUITING
Shanghai
Contact Information
Primary
Xiangyu Kong, MD
xiangyukong185@hotmail.com
13564644397
Time Frame
Start Date: 2024-01-01
Estimated Completion Date: 2026-07-30
Participants
Target number of participants: 300
Treatments
pancreatic mass diagnosed benign
Through pathological examination, radiological examination and follow-up, these patients are finally diagnosed with benign pancreatic mass.
pancreatic mass diagnosed malignant
Through pathological examination, radiological examination and follow-up, these patients are finally diagnosed with pancreaitic cancer.
Related Therapeutic Areas
Sponsors
Leads: Changhai Hospital